Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro. [electronic resource]
Producer: 20160810Description: 1547-1560 p. digitalISSN:- 1559-1182
- Animals
- Antiviral Agents -- pharmacology
- Brain -- metabolism
- Cells, Cultured
- Down-Regulation -- drug effects
- Encephalitis, Herpes Simplex -- prevention & control
- Glucosides -- pharmacology
- Herpesvirus 1, Human
- Hydrolyzable Tannins -- pharmacology
- Interleukin-6 -- biosynthesis
- Intracellular Signaling Peptides and Proteins -- biosynthesis
- Lipopeptides -- toxicity
- Male
- Membrane Glycoproteins -- biosynthesis
- Mice
- Mice, Inbred BALB C
- Microglia -- drug effects
- Myeloid Differentiation Factor 88 -- biosynthesis
- NF-kappa B -- biosynthesis
- Nerve Tissue Proteins -- biosynthesis
- Phosphorylation -- drug effects
- Protein Processing, Post-Translational -- drug effects
- RNA Interference
- RNA, Messenger -- biosynthesis
- RNA, Small Interfering -- genetics
- Receptors, Interleukin-1 -- biosynthesis
- Signal Transduction -- drug effects
- TNF Receptor-Associated Factor 6 -- biosynthesis
- Toll-Like Receptor 2 -- antagonists & inhibitors
- Tumor Necrosis Factor-alpha -- biosynthesis
- p38 Mitogen-Activated Protein Kinases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.